Dynavax Technologies (DVAX) Catches Eye: Stock Rises 5.2%

Zacks

Dynavax Technologies Corporation (DVAX) was a big mover last session, as the company saw its shares rise by over 5% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This continues the recent uptrend of the company as the stock has now gained over 45% since Nov 6.

This drug manufacturer has seen three positive revisions and one negative revision over the last 30 days while its Zacks Consensus Estimate moved higher over the same time frame, suggesting that more solid trading could be ahead for Dynavax Technologies. So make sure to keep an eye on this stock going forward to see if this recent move higher can turn into more strength down the road.

Dynavax Technologies currently has a Zacks Rank #3 (Hold) while its Earnings ESP is 0.00%.

Some better-ranked stocks in the same sector include Actelion Ltd. (ALIOF), Heska Corporation (HSKA) and AMAG Pharmaceuticals, Inc. (AMAG). While Actelion and Heska Corporation hold a Zacks Rank #1 (Strong Buy), AMAG Pharmaceuticals carries a Zacks Rank #2 (Buy).

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>




Zacks Investment Research

View Comments (0)